Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07226609

A Dietary Study for People With Multiple Myeloma

A Decentralized Randomized Dietary Trial in Newly Diagnosed Multiple Myeloma - NUTRIVENTION5

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
220 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to find out whether a dietary intervention can affect treatment response and/or quality of life for people with newly diagnosed multiple myeloma receiving standard induction chemotherapy with daratumumab (or isatuximab), lenalidomide, bortezomib, and dexamethasone (DRVd). The researchers will measure quality of life by having participants complete questionnaires. The study will investigate the effects of diet on quality of life, treatment response, and other disease, microbiome, and immune markers.

Conditions

Interventions

TypeNameDescription
OTHERnutrition counseling and coachingIn addition to individual counseling, patients will be able to join optional group sessions every 2 weeks as well as text message check-ins for survey completion reminders. Patients will receive 12 frozen, fixed pre-made lunch and dinner shipped to their home weekly from Modify Health for 12 weeks.
OTHERdietary guidelines, research dietitian visitParticipants will have phone calls with a member of the study team every 4 weeks as well as text message check-ins for survey completion reminders. At the end of standard induction chemotherapy, participants will have a phone call or video call with a dietitian
BEHAVIORALQuestionnairesBlock FFQ survey, EORTC QLQ C30 survey, EORTC MY20 survey, Pre intervention survey, Post intervention survey
OTHERFrozen pre-prepared mealsPatients will receive 12 frozen, fixed pre-made lunch and dinner shipped to their home weekly from Modify Health for 12 weeks.

Timeline

Start date
2025-11-04
Primary completion
2028-11-01
Completion
2028-11-01
First posted
2025-11-10
Last updated
2025-12-30

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT07226609. Inclusion in this directory is not an endorsement.